ATE282634T1 - Chaperonin 10 - Google Patents

Chaperonin 10

Info

Publication number
ATE282634T1
ATE282634T1 AT95902003T AT95902003T ATE282634T1 AT E282634 T1 ATE282634 T1 AT E282634T1 AT 95902003 T AT95902003 T AT 95902003T AT 95902003 T AT95902003 T AT 95902003T AT E282634 T1 ATE282634 T1 AT E282634T1
Authority
AT
Austria
Prior art keywords
seq
antibodies
cpn
cpn10
raised against
Prior art date
Application number
AT95902003T
Other languages
English (en)
Inventor
Halle Morton
Alice Christina Cavanagh
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPM8234A external-priority patent/AUPM823494A0/en
Application filed by Univ Queensland filed Critical Univ Queensland
Application granted granted Critical
Publication of ATE282634T1 publication Critical patent/ATE282634T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biophysics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Neurosurgery (AREA)
AT95902003T 1993-11-30 1994-11-30 Chaperonin 10 ATE282634T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPM270593 1993-11-30
AUPM8234A AUPM823494A0 (en) 1994-09-16 1994-09-16 Diagnostic and therapeutic uses of chaperonin 10
PCT/AU1994/000740 WO1995015338A1 (en) 1993-11-30 1994-11-30 Chaperonin 10

Publications (1)

Publication Number Publication Date
ATE282634T1 true ATE282634T1 (de) 2004-12-15

Family

ID=25644587

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95902003T ATE282634T1 (de) 1993-11-30 1994-11-30 Chaperonin 10

Country Status (11)

Country Link
US (3) US6113899A (de)
EP (2) EP0733071A4 (de)
JP (3) JP3545408B2 (de)
AT (1) ATE282634T1 (de)
AU (2) AU684578B2 (de)
CA (1) CA2177179C (de)
DE (1) DE69434137T2 (de)
ES (1) ES2233938T3 (de)
NZ (2) NZ276670A (de)
PT (1) PT731811E (de)
WO (2) WO1995015339A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT731811E (pt) * 1993-11-30 2005-04-29 Univ Queensland Chaperonina 10
JP2001509396A (ja) * 1997-07-10 2001-07-24 メディカル リサーチ カウンシル シャペロン断片
US6007821A (en) * 1997-10-16 1999-12-28 Fordham University Method and compositions for the treatment of autoimmune disease using heat shock proteins
US6475490B1 (en) 1998-10-19 2002-11-05 Fordham University Compositions and methods for promoting tissue repair using heat shock proteins
AUPP823999A0 (en) * 1999-01-20 1999-02-11 University Of Queensland, The A treatment
GB0028122D0 (en) * 2000-11-17 2001-01-03 St Georges Entpr Ltd Method
CN100406891C (zh) * 2001-06-27 2008-07-30 詹森药业有限公司 利用EPF受体鉴定结合或调节hDRR活性的化合物以及hDRR的分离
AU2002952492A0 (en) 2002-11-06 2002-11-21 Cbio Limited Chaperonin 10 immunosuppression
GB0226105D0 (en) * 2002-11-08 2002-12-18 St Georges S Entpr Ltd Pain relief agents
US20070275890A1 (en) * 2004-01-16 2007-11-29 Johnson Barbara J Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion
CN101309934B (zh) 2005-08-31 2014-02-12 悉生物有限公司 修饰的伴侣蛋白10
JP2009511610A (ja) * 2005-10-20 2009-03-19 シービーアイオー リミテッド 過敏症治療
AU2006303826B2 (en) * 2005-10-20 2012-07-19 Cbio Limited Treatment of hypersensitivity
MX2008011167A (es) * 2006-03-02 2008-11-12 Cbio Ltd Regulaciòn de respuestas inmunes mediante la modulaciòn de la funciòn de cèlulas presentadoras de antìgenos.
CA2720617A1 (en) 2008-04-11 2009-10-15 Cbio Limited Modified cpn10 and prr signalling
MX2012004067A (es) * 2009-10-09 2012-08-03 Cbio Ltd Variantes de la chaperonina 10.
US20110243921A1 (en) * 2010-03-30 2011-10-06 Cbio Limited Prevention and treatment of cutaneous lupus erythematosus
KR101776013B1 (ko) * 2017-05-26 2017-09-07 (주)넥스젠바이오텍 항산화 활성 및 피부 세포 증식 효과가 증가한 열 충격 단백질 10과 브라제인 단백질의 융합단백질 및 이를 유효성분으로 함유하는 피부 주름 개선용 화장료 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2192634B (en) * 1985-03-12 1990-03-21 Univ Queensland Method of detecting early pregnancy factor (epf) in mammals, purifying epf and method for providing a monoclonal antibody
AU599021B2 (en) * 1985-03-12 1990-07-12 University Of Queensland, The Method for detecting early pregnancy factor (epf) in mammals,purifying epf and method for producing a monoclonal antibody
EP0345260A4 (de) * 1986-12-22 1990-05-14 Univ Queensland Verfahren zur behandlung von säugetieren mit antikörpern gegen den frühempfangnisfaktor (epf).
AU1086988A (en) * 1986-12-22 1988-07-15 University Of Queensland, The Method of treatment of mammals using antibodies to early pregnancy factor (epf)
PT731811E (pt) * 1993-11-30 2005-04-29 Univ Queensland Chaperonina 10

Also Published As

Publication number Publication date
JP3986481B2 (ja) 2007-10-03
AU1103495A (en) 1995-06-19
US7358329B2 (en) 2008-04-15
JP3545408B2 (ja) 2004-07-21
CA2177179A1 (en) 1995-06-08
EP0731811B1 (de) 2004-11-17
WO1995015339A1 (en) 1995-06-08
EP0733071A4 (de) 1997-02-26
AU684578B2 (en) 1997-12-18
AU684577B2 (en) 1997-12-18
CA2177179C (en) 2006-10-17
AU1103695A (en) 1995-06-19
DE69434137D1 (en) 2004-12-23
ES2233938T3 (es) 2005-06-16
JPH09505811A (ja) 1997-06-10
US20030175280A1 (en) 2003-09-18
EP0731811A1 (de) 1996-09-18
DE69434137T2 (de) 2005-12-01
JP3987104B2 (ja) 2007-10-03
EP0733071A1 (de) 1996-09-25
JPH09506431A (ja) 1997-06-24
NZ276670A (en) 1998-01-26
WO1995015338A1 (en) 1995-06-08
PT731811E (pt) 2005-04-29
NZ276672A (en) 1998-01-26
US6417334B1 (en) 2002-07-09
US6113899A (en) 2000-09-05
JP2004067698A (ja) 2004-03-04
EP0731811A4 (de) 2003-05-28

Similar Documents

Publication Publication Date Title
ATE282634T1 (de) Chaperonin 10
DE69838143D1 (de) Antimikrobielle peptide
NZ333999A (en) GnRH-leukotoxin chimeric proteins for use in vaccines
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
ATE355074T1 (de) Hybrid aus interferon-alpha und immunglobulin fc- fragment verbunden durch ein nicht immunogenes peptid
AU4778101A (en) Novel polypeptides, and nucleic acids encoding the same
GB9108652D0 (en) Immunoreactive compounds
CA2290485A1 (en) Method for the production of non-immunogenic proteins
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
EP1619202A3 (de) Immunotherapeutische Methoden mit Verwendung von WT-1 and GATA-1 Epitopen
AU7565991A (en) Variant cd44 surface proteins, dna sequences coding them, antibodies against these proteins and their use in diagnosis and therapy
ATE301714T1 (de) Insulinartigen wachstumsfaktor bindendes protein -3 variante
ATE357526T1 (de) Modifizierte hcv peptid-impfstoffe
WO1991011462A3 (en) Merosin, nucleic acids encoding, fragments and uses thereof
ATE395361T1 (de) Das h-y antigen
NO20011263D0 (no) Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav
CA2163805A1 (en) Novel activating factor of leukocytes
DE69827880D1 (de) Iga1-protease fragment als trägerpeptid
RU96118282A (ru) Пептиды для ингибирования высвобождения пепсина
NZ606260A (en) Novel polypeptides involved in immune response
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
SE0002738D0 (sv) Electric actuator
NZ509284A (en) Tumour antigen peptide derived from SART-that binds to HLA-A24 antigen thereby facilitating recognition by a T call
WO2000026240A3 (en) Streptococcal alpha2m-binding protein
SE0002728D0 (sv) New compound

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties